AstraZeneca holds 2 European energy assets totalling 46 MW of equity capacity, headquartered in United Kingdom.
0% of that capacity is renewable and 50% is fossil-fired.
Sources: asset records from Global Energy Monitor. Equity capacity is nameplate weighted by stated ownership share. All owners